U.S. health advisers endorsed a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, putting the country on the cusp of adding an easier-to-use option to fight the pandemic. The U.S. Food and Drug Administration is expected to quickly approve it for emergency use.